Renal replacement therapy I: indications and timing

Area of Science:

• Nephrology
• Critical Care Medicine
• Internal Medicine

Background:

• Indications for initiating renal replacement therapy (RRT) in acute kidney injury (AKI) are not well-defined.
• Commonly accepted triggers like fluid overload and electrolyte imbalances lack specific initiation criteria, leading to subjective clinical decisions.
• Progressive azotemia without overt uremic symptoms is also a frequent RRT indication, but consensus on azotemia thresholds is absent.

Purpose of the Study:

• To review current clinical data on the timing and initiation of renal support in patients with acute renal failure.
• To highlight the controversies and lack of consensus regarding established indications for RRT in AKI.
• To emphasize the need for further research to clarify optimal RRT initiation strategies.

Main Methods:

• A comprehensive review of existing clinical data and literature concerning RRT initiation in acute renal failure.
• Analysis of commonly cited indications, including volume overload, metabolic acidosis, hyperkalemia, and azotemia.
• Identification of subjective criteria and lack of consensus in current RRT decision-making.

Main Results:

• Established indications for RRT in AKI, such as fluid overload and electrolyte disturbances, are based on subjective clinical judgment.
• There is no universal agreement on the degree of azotemia that necessitates RRT initiation.
• Current practices for timing RRT in AKI are inconsistent and lack definitive evidence-based guidelines.

Conclusions:

• The precise indications and optimal timing for initiating renal replacement therapy in acute renal failure require further investigation.
• Prospective evaluation through randomized clinical trials is essential to resolve current controversies.
• Evidence-based guidelines are needed to standardize RRT initiation in AKI patients.